9 The Therapeutic Landscape of FcRn Antagonists Increasing IgG catabolism by specific FcRn targeting has proven to be a safe and efficacious strategy to lower the levels of autoreactive IgG in several autoimmune diseases
Mechanistically, it is documented to stimulate collagen, promote angiogenesis, and suppress pro-inflammatory cytokines like IL-6 and TNF-alpha
Tirzepatide users show elevated risk of cholecystitis and cholelithiasis compared to baseline
Injectable Routes for GI Indications A subset of practitioners prescribes BPC-157 in oral capsule or liquid form specifically for GI tract pathology, including inflammatory bowel conditions and gut permeability issues
While adverse effects are rare, possible side effects can include mild headaches, dizziness, or fatigue in some cases
Research indicates that retatrutide solutions are most stable at pH 4 to 5